Aplastic anemia is a rare but serious disorder in which the bone marrow stops producing an adequate number of all types of blood cells: red blood cells, white blood cells, and platelets. This condition leads to anemia, an increased susceptibility to infections, and bleeding. Treatment of aplastic anemia in children is aimed at eliminating the underlying cause when identifiable and restoring normal bone marrow function.
Main approaches to the treatment of aplastic anemia in Belarus
- Supportive therapy. Treatment focuses on symptom control and includes blood transfusions to maintain adequate levels of red blood cells and platelets. Transfusions help temporarily correct anemia and prevent bleeding. Antibacterial, antifungal, and antiviral medications are prescribed for the prevention and treatment of infections, as reduced white blood cell counts make the body highly vulnerable to infectious complications.
- Immunosuppressive therapy. In children, aplastic anemia is often associated with immune-mediated destruction of bone marrow cells. Immunosuppressive drugs reduce abnormal immune activity and allow bone marrow function to recover. In some cases, corticosteroids are used in combination with other immunosuppressive agents to enhance therapeutic efficacy.
- Bone marrow stimulation. Medications that stimulate blood cell production may be used to increase white blood cell and red blood cell counts.
- Bone marrow transplantation (hematopoietic stem cell transplantation). This is the most effective treatment for aplastic anemia in children, particularly when a matched donor is available (for example, a sibling). Stem cell transplantation can fully restore bone marrow function. This approach is more commonly used in children and young patients, as they generally tolerate the procedure better. If no suitable related donor is available, an unrelated donor search is conducted through international registries.
- Gene therapy (under development). In selected cases of genetically determined aplastic anemia, novel gene therapy approaches are being investigated. These treatments are currently limited and are available only within clinical trials.
Living with aplastic anemia
- Infection prevention. The child should avoid contact with sick individuals, and caregivers should carefully maintain hand hygiene and environmental cleanliness at home. In some cases, protective isolation may be required to reduce the risk of infection.
- Nutritional support. The childβs diet should be balanced and rich in vitamins and minerals. Additional vitamin supplementation may be necessary, especially if nutrient absorption is impaired.
- Physical activity. Children are advised to avoid contact sports and activities with a high risk of injury, particularly when platelet levels are low, in order to reduce the risk of bleeding.
Treatment of aplastic anemia in children requires a comprehensive and closely monitored approach under the supervision of pediatric hematologists. Immunosuppressive therapy, blood transfusions, and bone marrow transplantation remain the cornerstone treatment options. Early diagnosis and timely initiation of therapy are crucial to minimize complications and improve the childβs quality of life. Family support and regular follow-up visits play a key role in achieving successful treatment outcomes.
Q&A
ΠΠ°, Π² Π½Π΅ΠΊΠΎΡΠΎΡΡΡ ΡΠ»ΡΡΠ°ΡΡ , ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ ΠΏΠΎΡΠ»Π΅ ΡΡΠΏΠ΅ΡΠ½ΠΎΠΉ ΠΏΠ΅ΡΠ΅ΡΠ°Π΄ΠΊΠΈ ΠΊΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π°, Π°ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π°Π½Π΅ΠΌΠΈΡ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΏΠΎΠ»Π½ΠΎΡΡΡΡ Π²ΡΠ»Π΅ΡΠ΅Π½Π°. ΠΠ΄Π½Π°ΠΊΠΎ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΠΈ ΡΡΠ΅Π±ΡΠ΅Ρ ΡΡΠ°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ.
Π Π½Π΅ΠΊΠΎΡΠΎΡΡΡ ΡΠ»ΡΡΠ°ΡΡ Π°ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π°Π½Π΅ΠΌΠΈΡ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΡΠ²ΡΠ·Π°Π½Π° Ρ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ ΠΈΠ»ΠΈ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΌΡΡΠ°ΡΠΈΡΠΌΠΈ. ΠΠ΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΏΠΎΠ»Π΅Π·Π½ΡΠΌ Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΠΏΡΠΈΡΠΈΠ½Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ.
